Switch to:
More From Other Websites
TAL Education, Team Health Join The IBD 50 Resistance Aug 01 2014
Pharmacyclics Q2 Earnings Get Mixed Reception Aug 01 2014
Wall Street Transcript Interview with Charles R. Kummeth, the President and CEO of Bio-Techne (TECH) Aug 01 2014
Merck, J&J, Baxter Provide Healthy Dividend Stream Jul 30 2014
Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues Jul 30 2014
[video] Cramer's Mad Dash: REGN breaks through Jul 30 2014
$1,000 Sovaldi now hepatitis treatment of choice Jul 29 2014
$1,000 Sovaldi now hepatitis treatment of choice Jul 29 2014
Aetna Earnings Beat But Rising Medical Costs A Worry Jul 29 2014
Fairchild Semiconductor, E*Trade Financial, Gilead Sciences, Roche and Biogen Idec highlighted as... Jul 29 2014
Gilead's Oncology Drug Recommended for Approval in the EU Jul 28 2014
Why Gilead Sciences (GILD) Stock Is Up Today Jul 28 2014
High cost of hepatitis C treatment pills is hard to swallow Jul 27 2014
Drug cocktails point the way towards relief for all hepatitis C sufferers Jul 27 2014
Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous... Jul 25 2014
[video] The push back on Sovaldi Jul 25 2014
[video] The $84,000 drug debate Jul 25 2014
[video] Drug costs hit insurers: Gilead still a buy? Jul 25 2014
Did Gilead's Sovaldi Cause WellCare's Woes? Jul 25 2014
AbbVie Beats Earnings Views, Sees Slower Humira Gain Jul 25 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide